Pre-order Enquiry
Request Free Sample
Global Duchenne Muscular Dystrophy Market Research Report 2022(Status and Outlook)
SKU ID : BOS-21146210 | Publishing Date : 22-Jun-2022 | No. of pages : 102
Detailed TOC of Global Duchenne Muscular Dystrophy Market Research Report 2022(Status and Outlook)
TABLE OF CONTENTS1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Duchenne Muscular Dystrophy
1.2 Key Market Segments
1.2.1 Duchenne Muscular Dystrophy Segment by Type
1.2.2 Duchenne Muscular Dystrophy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Duchenne Muscular Dystrophy Market Overview
2.1 Global Market Overview
2.1.1 Global Duchenne Muscular Dystrophy Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Duchenne Muscular Dystrophy Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Duchenne Muscular Dystrophy Market Competitive Landscape
3.1 Global Duchenne Muscular Dystrophy Sales by Manufacturers (2017-2022)
3.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturers (2017-2022)
3.3 Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Duchenne Muscular Dystrophy Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Duchenne Muscular Dystrophy Sales Sites, Area Served, Product Type
3.6 Duchenne Muscular Dystrophy Market Competitive Situation and Trends
3.6.1 Duchenne Muscular Dystrophy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Duchenne Muscular Dystrophy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Duchenne Muscular Dystrophy Industry Chain Analysis
4.1 Duchenne Muscular Dystrophy Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Duchenne Muscular Dystrophy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Duchenne Muscular Dystrophy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2022)
6.3 Global Duchenne Muscular Dystrophy Market Size Market Share by Type (2017-2022)
6.4 Global Duchenne Muscular Dystrophy Price by Type (2017-2022)
7 Duchenne Muscular Dystrophy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Duchenne Muscular Dystrophy Market Sales by Application (2017-2022)
7.3 Global Duchenne Muscular Dystrophy Market Size (M USD) by Application (2017-2022)
7.4 Global Duchenne Muscular Dystrophy Sales Growth Rate by Application (2017-2022)
8 Duchenne Muscular Dystrophy Market Segmentation by Region
8.1 Global Duchenne Muscular Dystrophy Sales by Region
8.1.1 Global Duchenne Muscular Dystrophy Sales by Region
8.1.2 Global Duchenne Muscular Dystrophy Sales Market Share by Region
8.2 North America
8.2.1 North America Duchenne Muscular Dystrophy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Duchenne Muscular Dystrophy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Duchenne Muscular Dystrophy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Duchenne Muscular Dystrophy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Duchenne Muscular Dystrophy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Sarepta Therapeutics
9.1.1 Sarepta Therapeutics Duchenne Muscular Dystrophy Basic Information
9.1.2 Sarepta Therapeutics Duchenne Muscular Dystrophy Product Overview
9.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Product Market Performance
9.1.4 Sarepta Therapeutics Business Overview
9.1.5 Sarepta Therapeutics Duchenne Muscular Dystrophy SWOT Analysis
9.1.6 Sarepta Therapeutics Recent Developments
9.2 PTC Therapeutics
9.2.1 PTC Therapeutics Duchenne Muscular Dystrophy Basic Information
9.2.2 PTC Therapeutics Duchenne Muscular Dystrophy Product Overview
9.2.3 PTC Therapeutics Duchenne Muscular Dystrophy Product Market Performance
9.2.4 PTC Therapeutics Business Overview
9.2.5 PTC Therapeutics Duchenne Muscular Dystrophy SWOT Analysis
9.2.6 PTC Therapeutics Recent Developments
9.3 Pfizer
9.3.1 Pfizer Duchenne Muscular Dystrophy Basic Information
9.3.2 Pfizer Duchenne Muscular Dystrophy Product Overview
9.3.3 Pfizer Duchenne Muscular Dystrophy Product Market Performance
9.3.4 Pfizer Business Overview
9.3.5 Pfizer Duchenne Muscular Dystrophy SWOT Analysis
9.3.6 Pfizer Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Duchenne Muscular Dystrophy Basic Information
9.4.2 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Overview
9.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Duchenne Muscular Dystrophy SWOT Analysis
9.4.6 Bristol-Myers Squibb Recent Developments
9.5 Italfarmaco
9.5.1 Italfarmaco Duchenne Muscular Dystrophy Basic Information
9.5.2 Italfarmaco Duchenne Muscular Dystrophy Product Overview
9.5.3 Italfarmaco Duchenne Muscular Dystrophy Product Market Performance
9.5.4 Italfarmaco Business Overview
9.5.5 Italfarmaco Duchenne Muscular Dystrophy SWOT Analysis
9.5.6 Italfarmaco Recent Developments
9.6 Santhera Pharmaceuticals
9.6.1 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Basic Information
9.6.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Overview
9.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Market Performance
9.6.4 Santhera Pharmaceuticals Business Overview
9.6.5 Santhera Pharmaceuticals Recent Developments
10 Duchenne Muscular Dystrophy Market Forecast by Region
10.1 Global Duchenne Muscular Dystrophy Market Size Forecast
10.2 Global Duchenne Muscular Dystrophy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Duchenne Muscular Dystrophy Market Size Forecast by Country
10.2.3 Asia Pacific Duchenne Muscular Dystrophy Market Size Forecast by Region
10.2.4 South America Duchenne Muscular Dystrophy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Duchenne Muscular Dystrophy by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Duchenne Muscular Dystrophy Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Duchenne Muscular Dystrophy by Type (2022-2028)
11.1.2 Global Duchenne Muscular Dystrophy Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Duchenne Muscular Dystrophy by Type (2022-2028)
11.2 Global Duchenne Muscular Dystrophy Market Forecast by Application (2022-2028)
11.2.1 Global Duchenne Muscular Dystrophy Sales (K Units) Forecast by Application
11.2.2 Global Duchenne Muscular Dystrophy Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
List of Figures, Tables and Charts Available in Global Duchenne Muscular Dystrophy Market Research Report 2022(Status and Outlook)
LIST OF TABLESTable 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Duchenne Muscular Dystrophy Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Duchenne Muscular Dystrophy Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Duchenne Muscular Dystrophy Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy as of 2021)
Table 10. Global Market Duchenne Muscular Dystrophy Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Duchenne Muscular Dystrophy Sales Sites and Area Served
Table 12. Manufacturers Duchenne Muscular Dystrophy Product Type
Table 13. Global Duchenne Muscular Dystrophy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Duchenne Muscular Dystrophy
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Duchenne Muscular Dystrophy Market Challenges
Table 22. Market Restraints
Table 23. Global Duchenne Muscular Dystrophy Sales by Type (K Units)
Table 24. Global Duchenne Muscular Dystrophy Market Size by Type (M USD)
Table 25. Global Duchenne Muscular Dystrophy Sales (K Units) by Type (2017-2022)
Table 26. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2022)
Table 27. Global Duchenne Muscular Dystrophy Market Size (M USD) by Type (2017-2022)
Table 28. Global Duchenne Muscular Dystrophy Market Size Share by Type (2017-2022)
Table 29. Global Duchenne Muscular Dystrophy Price (USD/Unit) by Type (2017-2022)
Table 30. Global Duchenne Muscular Dystrophy Sales (K Units) by Application
Table 31. Global Duchenne Muscular Dystrophy Market Size by Application
Table 32. Global Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Units)
Table 33. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2022)
Table 34. Global Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (M USD)
Table 35. Global Duchenne Muscular Dystrophy Market Share by Application (2017-2022)
Table 36. Global Duchenne Muscular Dystrophy Sales Growth Rate by Application (2017-2022)
Table 37. Global Duchenne Muscular Dystrophy Sales by Region (2017-2022) & (K Units)
Table 38. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2017-2022)
Table 39. North America Duchenne Muscular Dystrophy Sales by Country (2017-2022) & (K Units)
Table 40. Europe Duchenne Muscular Dystrophy Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Duchenne Muscular Dystrophy Sales by Region (2017-2022) & (K Units)
Table 42. South America Duchenne Muscular Dystrophy Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Duchenne Muscular Dystrophy Sales by Region (2017-2022) & (K Units)
Table 44. Sarepta Therapeutics Duchenne Muscular Dystrophy Basic Information
Table 45. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Overview
Table 46. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Sarepta Therapeutics Business Overview
Table 48. Sarepta Therapeutics Duchenne Muscular Dystrophy SWOT Analysis
Table 49. Sarepta Therapeutics Recent Developments
Table 50. PTC Therapeutics Duchenne Muscular Dystrophy Basic Information
Table 51. PTC Therapeutics Duchenne Muscular Dystrophy Product Overview
Table 52. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. PTC Therapeutics Business Overview
Table 54. PTC Therapeutics Duchenne Muscular Dystrophy SWOT Analysis
Table 55. PTC Therapeutics Recent Developments
Table 56. Pfizer Duchenne Muscular Dystrophy Basic Information
Table 57. Pfizer Duchenne Muscular Dystrophy Product Overview
Table 58. Pfizer Duchenne Muscular Dystrophy Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Pfizer Business Overview
Table 60. Pfizer Duchenne Muscular Dystrophy SWOT Analysis
Table 61. Pfizer Recent Developments
Table 62. Bristol-Myers Squibb Duchenne Muscular Dystrophy Basic Information
Table 63. Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Overview
Table 64. Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Duchenne Muscular Dystrophy SWOT Analysis
Table 67. Bristol-Myers Squibb Recent Developments
Table 68. Italfarmaco Duchenne Muscular Dystrophy Basic Information
Table 69. Italfarmaco Duchenne Muscular Dystrophy Product Overview
Table 70. Italfarmaco Duchenne Muscular Dystrophy Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Italfarmaco Business Overview
Table 72. Italfarmaco Duchenne Muscular Dystrophy SWOT Analysis
Table 73. Italfarmaco Recent Developments
Table 74. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Basic Information
Table 75. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Overview
Table 76. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Santhera Pharmaceuticals Business Overview
Table 78. Santhera Pharmaceuticals Recent Developments
Table 79. Global Duchenne Muscular Dystrophy Sales Forecast by Region (K Units)
Table 80. Global Duchenne Muscular Dystrophy Market Size Forecast by Region (M USD)
Table 81. North America Duchenne Muscular Dystrophy Sales Forecast by Country (2022-2028) & (K Units)
Table 82. North America Duchenne Muscular Dystrophy Market Size Forecast by Country (2022-2028) & (M USD)
Table 83. Europe Duchenne Muscular Dystrophy Sales Forecast by Country (2022-2028) & (K Units)
Table 84. Europe Duchenne Muscular Dystrophy Market Size Forecast by Country (2022-2028) & (M USD)
Table 85. Asia Pacific Duchenne Muscular Dystrophy Sales Forecast by Region (2022-2028) & (K Units)
Table 86. Asia Pacific Duchenne Muscular Dystrophy Market Size Forecast by Region (2022-2028) & (M USD)
Table 87. South America Duchenne Muscular Dystrophy Sales Forecast by Country (2022-2028) & (K Units)
Table 88. South America Duchenne Muscular Dystrophy Market Size Forecast by Country (2022-2028) & (M USD)
Table 89. Middle East and Africa Duchenne Muscular Dystrophy Consumption Forecast by Country (2022-2028) & (Units)
Table 90. Middle East and Africa Duchenne Muscular Dystrophy Market Size Forecast by Country (2022-2028) & (M USD)
Table 91. Global Duchenne Muscular Dystrophy Sales Forecast by Type (2022-2028) & (K Units)
Table 92. Global Duchenne Muscular Dystrophy Market Size Forecast by Type (2022-2028) & (M USD)
Table 93. Global Duchenne Muscular Dystrophy Price Forecast by Type (2022-2028) & (USD/Unit)
Table 94. Global Duchenne Muscular Dystrophy Sales (K Units) Forecast by Application (2022-2028)
Table 95. Global Duchenne Muscular Dystrophy Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Duchenne Muscular Dystrophy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Duchenne Muscular Dystrophy Market Size (M USD), 2017-2028
Figure 5. Global Duchenne Muscular Dystrophy Market Size (M USD) (2017-2028)
Figure 6. Global Duchenne Muscular Dystrophy Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Duchenne Muscular Dystrophy Market Size (M USD) by Country (M USD)
Figure 11. Duchenne Muscular Dystrophy Sales Share by Manufacturers in 2020
Figure 12. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers in 2020
Figure 13. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Duchenne Muscular Dystrophy Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Duchenne Muscular Dystrophy Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Duchenne Muscular Dystrophy Market Share by Type
Figure 18. Sales Market Share of Duchenne Muscular Dystrophy by Type (2017-2022)
Figure 19. Sales Market Share of Duchenne Muscular Dystrophy by Type in 2021
Figure 20. Market Size Share of Duchenne Muscular Dystrophy by Type (2017-2022)
Figure 21. Market Size Market Share of Duchenne Muscular Dystrophy by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Duchenne Muscular Dystrophy Market Share by Application
Figure 24. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2022)
Figure 25. Global Duchenne Muscular Dystrophy Sales Market Share by Application in 2021
Figure 26. Global Duchenne Muscular Dystrophy Market Share by Application (2017-2022)
Figure 27. Global Duchenne Muscular Dystrophy Market Share by Application in 2020
Figure 28. Global Duchenne Muscular Dystrophy Sales Growth Rate by Application (2017-2022)
Figure 29. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2017-2022)
Figure 30. North America Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Duchenne Muscular Dystrophy Sales Market Share by Country in 2020
Figure 32. U.S. Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Duchenne Muscular Dystrophy Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Duchenne Muscular Dystrophy Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Duchenne Muscular Dystrophy Sales Market Share by Country in 2020
Figure 37. Germany Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Duchenne Muscular Dystrophy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Region in 2020
Figure 44. China Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Duchenne Muscular Dystrophy Sales and Growth Rate (K Units)
Figure 50. South America Duchenne Muscular Dystrophy Sales Market Share by Country in 2020
Figure 51. Brazil Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Duchenne Muscular Dystrophy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Duchenne Muscular Dystrophy Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Duchenne Muscular Dystrophy Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Duchenne Muscular Dystrophy Market Share Forecast by Type (2022-2028)
Figure 65. Global Duchenne Muscular Dystrophy Sales Forecast by Application (2022-2028)
Figure 66. Global Duchenne Muscular Dystrophy Market Share Forecast by Application (2022-2028)
Keyplayers in Global Duchenne Muscular Dystrophy Market Research Report 2022(Status and Outlook)
•Sarepta Therapeutics•PTC Therapeutics
•Pfizer
•Bristol-Myers Squibb
•Italfarmaco
•Santhera Pharmaceuticals
Request Sample
Request Discount
